...
首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Cardiac troponin I cutoff values to predict postoperative cardiac complications after circulatory arrest and profound hypothermia.
【24h】

Cardiac troponin I cutoff values to predict postoperative cardiac complications after circulatory arrest and profound hypothermia.

机译:心脏肌钙蛋白I的临界值可预测循环骤停和深低温后的心脏并发症。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Cardiac failure and myocardial infarction are complications of thoracic aorta, thoracoabdominal aorta, or aortic arch surgery, especially when surgery is performed using profound hypothermia and circulatory arrest (PHCA). Moreover, the diagnosis of non-Q-wave postoperative myocardial infarction (PMI) is challenging because there is no gold standard. The aims of this study were to determine values for cardiac troponin I (cTnl) in patients undergoing aortic arch or thoracoabdominal aortic surgery with PHCA who were free of cardiac complications in the postoperative period, and to test the validity of cutoff values of cTnl to predict postoperative cardiac complications in such patients. DESIGN: Prospective, nonrandomized study. SETTING: Single university hospital; Departments of Anesthesiology, Biochemistry and Vascular Surgery. PARTICIPANTS: Fifty-two consecutive patients were studied over a 2-year period. None was excluded, even patients who underwent emergency surgery. INTERVENTIONS: Patients undergoing aortic arch or thoracoabdominal aortic surgery with PHCA were studied. Thirty patients undergoing coronary artery bypass grafting (CABG) in the same period constituted a control group. MEASUREMENTS AND MAIN RESULTS: The cTnl concentrations were determined using an immunoenzymofluorometric assay on a Stratus analyzer (Dade, Massy, France) on blood samples obtained at recovery and on day 1 (D1) and D2. Seventeen patients developed a cardiac complication, which was lethal in 10 patients. In patients without cardiac complication, the peak level for cTnl was observed on D1. Cutoff values of cTnl were identical in both the CABG control group (11 .6 microg/mL) and the sternotomy group (12.2 microg/mL), but were significantly greater (20.5 microg/mL) in patients with a thoracotomy approach. Sensitivity and specificity of these cutoff values were high in both groups (control group, sensitivity = 100%, specificity = 100%; sternotomy group, sensitivity = 78%, specificity = 100%; thoracotomy group, sensitivity = 100%, specificity = 94%). CONCLUSION: In patients who underwent surgery using PHCA for aortic arch or descending aorta repair, myocardial damage related to cardiac arrest, vents or fibrillation explains the increased cutoff value (12.2 microg/mL). This value is similar to patients undergoing CABG surgery through a sternotomy approach with cardioplegia administration. In contrast, and probably related to the absence of cardioplegia, patients undergoing surgery through a left thoracotomy approach had a greater cutoff value (20.5 microg/mL). Values of cTnl greater than these respective cutoff values were closely related to cardiac complications during the postoperative period.
机译:目的:心脏衰竭和心肌梗塞是胸主动脉,胸腹主动脉或主动脉弓手术的并发症,尤其是在使用深低温和循环停止(PHCA)进行手术时。而且,由于没有金标准,因此对非Q波术后心肌梗死(PMI)的诊断具有挑战性。这项研究的目的是确定在接受PHCA的主动脉弓或胸腹主动脉手术患者的心脏肌钙蛋白I(cTnl)的值,该值在术后期无心脏并发症,并检验cTnl的临界值是否可预测这类患者的术后心脏并发症。设计:前瞻性,非随机研究。地点:单一大学医院;麻醉学,生物化学和血管外科系。参与者:在为期2年的研究中,对52位连续患者进行了研究。没有人被排除在外,即使是接受急诊手术的患者。干预措施:对接受过PHCA的主动脉弓或胸腹主动脉手术患者进行了研究。同期接受冠状动脉旁路移植术(CABG)的30例患者为对照组。测量和主要结果:cTnl浓度的测定是在Stratus分析仪(法国马西省戴德市)上对恢复时以及在第1天(D1)和D2获得的血样进行免疫酶荧光法测定的。 17名患者发生了心脏并发症,其中10例致死。在没有心脏并发症的患者中,在D1观察到cTnl的峰值水平。在CABG对照组(11 .6 microg / mL)和胸骨切开术组(12.2 microg / mL)中,cTnl的临界值均相同,但在开胸手术患者中cTnl的临界值相同(20.5 microg / mL)。两组的这些临界值的敏感性和特异性均很高(对照组,敏感性= 100%,特异性= 100%;胸骨切开术组,敏感性= 78%,特异性= 100%;开胸手术组,敏感性= 100%,特异性= 94 %)。结论:在使用PHCA进行主动脉弓或降主动脉修复手术的患者中,与心脏骤停,通气或纤颤相关的心肌损伤可解释为临界值增加(12.2 microg / mL)。该值类似于通过心脏切开术通过胸骨切开术进行CABG手术的患者。相反,可能与没有心脏麻痹相关的是,通过左胸廓切开术进行手术的患者的临界值更高(20.5 microg / mL)。大于这些各自的临界值的cTnl值与术后期间的心脏并发症密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号